| Product Code: ETC7923472 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Transarterial Chemoembolization (TACE) Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Transarterial Chemoembolization (TACE) Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Transarterial Chemoembolization (TACE) Market - Industry Life Cycle |
3.4 Latvia Transarterial Chemoembolization (TACE) Market - Porter's Five Forces |
3.5 Latvia Transarterial Chemoembolization (TACE) Market Revenues & Volume Share, By Procedure Type, 2021 & 2031F |
3.6 Latvia Transarterial Chemoembolization (TACE) Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 Latvia Transarterial Chemoembolization (TACE) Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.8 Latvia Transarterial Chemoembolization (TACE) Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Latvia Transarterial Chemoembolization (TACE) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of liver cancer in Latvia |
4.2.2 Growing adoption of minimally invasive procedures for cancer treatment |
4.2.3 Advancements in technology leading to improved TACE procedures |
4.3 Market Restraints |
4.3.1 High cost associated with TACE treatment |
4.3.2 Lack of skilled healthcare professionals specialized in TACE procedures |
4.3.3 Stringent regulatory requirements for TACE products and procedures |
5 Latvia Transarterial Chemoembolization (TACE) Market Trends |
6 Latvia Transarterial Chemoembolization (TACE) Market, By Types |
6.1 Latvia Transarterial Chemoembolization (TACE) Market, By Procedure Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Procedure Type, 2021- 2031F |
6.1.3 Latvia Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Conventional TACE, 2021- 2031F |
6.1.4 Latvia Transarterial Chemoembolization (TACE) Market Revenues & Volume, By DEB-TACE, 2021- 2031F |
6.2 Latvia Transarterial Chemoembolization (TACE) Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 Latvia Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Unresectable HCC, 2021- 2031F |
6.2.3 Latvia Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Early-Stage HCC, 2021- 2031F |
6.3 Latvia Transarterial Chemoembolization (TACE) Market, By Product Type |
6.3.1 Overview and Analysis |
6.3.2 Latvia Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Chemotherapeutic Agents, 2021- 2031F |
6.3.3 Latvia Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Radiotherapeutic Agents, 2021- 2031F |
6.3.4 Latvia Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Drug-eluting Particles, 2021- 2031F |
6.3.5 Latvia Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Latvia Transarterial Chemoembolization (TACE) Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Latvia Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Latvia Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 Latvia Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Surgical Centers, 2021- 2031F |
6.4.5 Latvia Transarterial Chemoembolization (TACE) Market Revenues & Volume, By Others, 2021- 2031F |
7 Latvia Transarterial Chemoembolization (TACE) Market Import-Export Trade Statistics |
7.1 Latvia Transarterial Chemoembolization (TACE) Market Export to Major Countries |
7.2 Latvia Transarterial Chemoembolization (TACE) Market Imports from Major Countries |
8 Latvia Transarterial Chemoembolization (TACE) Market Key Performance Indicators |
8.1 Average waiting time for TACE procedure in Latvia |
8.2 Number of hospitals/clinics offering TACE treatment |
8.3 Patient satisfaction rate with TACE procedures |
8.4 Rate of complications or adverse events associated with TACE treatment |
8.5 Number of ongoing clinical trials for TACE advancements |
9 Latvia Transarterial Chemoembolization (TACE) Market - Opportunity Assessment |
9.1 Latvia Transarterial Chemoembolization (TACE) Market Opportunity Assessment, By Procedure Type, 2021 & 2031F |
9.2 Latvia Transarterial Chemoembolization (TACE) Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 Latvia Transarterial Chemoembolization (TACE) Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.4 Latvia Transarterial Chemoembolization (TACE) Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Latvia Transarterial Chemoembolization (TACE) Market - Competitive Landscape |
10.1 Latvia Transarterial Chemoembolization (TACE) Market Revenue Share, By Companies, 2024 |
10.2 Latvia Transarterial Chemoembolization (TACE) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here